PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?

J Nucl Med. 2024 May 1;65(5):818-819. doi: 10.2967/jnumed.123.266722.

Lena M Unterrainer^{1

2}, Kathleen Ruchalski³, Martin S Allen-Auerbach¹, Jeremie Calais¹, Matthias R Benz^{4

3

5}

¹ Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.
² Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
³ Department of Radiological Sciences, UCLA, Los Angeles, California; and.
⁴ Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; mbenz@mednet.ucla.edu.
⁵ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

No abstract available

MeSH terms